These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1876819)
41. Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease. Schneider LS; Farlow M Ann N Y Acad Sci; 1997 Sep; 826():317-22. PubMed ID: 9329702 [TBL] [Abstract][Full Text] [Related]
42. [Neuroprotective therapy of Alzheimer's disease?]. Mielke R Dtsch Med Wochenschr; 1996 Nov; 121(48):1515. PubMed ID: 8983909 [No Abstract] [Full Text] [Related]
44. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial]. Wallin A Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526 [No Abstract] [Full Text] [Related]
45. Alternatives in the treatment of memory loss in patients with Alzheimer's disease. Volger BW Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522 [TBL] [Abstract][Full Text] [Related]
46. Tacrine therapy for the dementia of Alzheimer's disease. Manning FC Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912 [TBL] [Abstract][Full Text] [Related]
48. Tacrine in Alzheimer's disease. Levy R Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126 [No Abstract] [Full Text] [Related]
49. Alzheimer's disease. Hier DB Surg Neurol; 1997 Jan; 47(1):84-5. PubMed ID: 8986173 [No Abstract] [Full Text] [Related]
50. No association between tacrine transaminitis and the glutathione transferase theta genotype in patients with Alzheimer's disease. De Sousa M; Pirmohamed M; Kitteringham NR; Woolf T; Park BK Pharmacogenetics; 1998 Aug; 8(4):353-5. PubMed ID: 9731722 [No Abstract] [Full Text] [Related]
52. (+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity. Shutske GM; Pierrat FA; Cornfeldt ML; Szewczak MR; Huger FP; Bores GM; Haroutunian V; Davis KL J Med Chem; 1988 Jul; 31(7):1278-9. PubMed ID: 3385720 [No Abstract] [Full Text] [Related]
53. Development of memory-enhancing agents in the treatment of Alzheimer's disease. Abernethy DR J Am Geriatr Soc; 1987 Oct; 35(10):957-8. PubMed ID: 2888798 [No Abstract] [Full Text] [Related]
54. Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors. Koepp R; Miles SH JAMA; 1999 Jun 23-30; 281(24):2287-8. PubMed ID: 10386551 [No Abstract] [Full Text] [Related]
55. [New therapeutic prospects in Alzheimer disease]. Rouhart F Rev Med Interne; 1995; 16(11):860-3. PubMed ID: 8570945 [TBL] [Abstract][Full Text] [Related]